Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinomaR M Bukowski, P Rayman, L Molto, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|December 1, 1991
Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experienceE M Hersh, B S Metch, F M Muggia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup studyC W Taylor, S Green, W S Dalton, et al.
Advances in Experimental Medicine and Biology|March 10, 2000
Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposisG D Stoner, G T Budd, R Ganapathi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancerS E Jones, J Erban, B Overmoyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposisR van Stolk, G Stoner, W L Hayton, et al.
Journal of the National Cancer Institute|March 20, 2018
Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27Kathrin Strasser-Weippl, Michaela J Higgins, Judith-Anne W Chapman, et al.
JCI Insight|September 14, 2021
Adrenal-permissive HSD3B1 genetic inheritance and risk of estrogen-driven postmenopausal breast cancerMegan L Kruse, Mona Patel, Jeffrey McManus, et al.
JNCI Cancer Spectrum|March 15, 2026
Long-Term follow-up of S0221, comparing alternative Dose-Schedules of anthracycline/taxane therapy in early breast cancerAzka Ali, William E Barlow, Halle C F Moore, et al.
Pageof 10